Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors.
This article is protected by copyright. All rights reserved.
PMID: 25974703 [PubMed - as supplied by publisher]
Source: Clinical Pharmacology and Therapeutics - Category: Drugs & Pharmacology Authors: Hicks JK, Bishop JR, Sangkuhl K, Müller DJ, Ji Y, Leckband SG, Leeder JS, Graham RL, Chiulli DL, LLerena A, Skaar TC, Scott SA, Stingl JC, Klein TE, Caudle KE, Gaedigk A Tags: Clin Pharmacol Ther Source Type: research
More News: Anxiety | Celexa | Citalopram | Depression | Drugs & Pharmacology | Lexapro | Paroxetine | Paxil | Sertraline | Zoloft